Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)
India flag India · Delayed Price · Currency is INR
4,541.00
+35.10 (0.78%)
Aug 11, 2026, 3:29 PM IST

NSE:SANOFICONR Income Statement

Millions INR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
9,4988,7847,2458,331
Revenue Growth
31.17%21.24%-13.04%-
Cost of Revenue
2,4562,3311,8772,291
Gross Profit
7,0426,4535,3686,041
Selling, General & Admin
1,6871,6591,2581,050
Other Operating Expenses
1,8261,7041,4041,709
Operating Expenses
3,6453,4802,7072,786
Operating Income
3,3972,9732,6613,255
Interest Expense
-20-20-39-
Interest & Investment Income
15215211860
Currency Exchange Gain (Loss)
28281-
Other Non Operating Income (Expenses)
154111.5
EBT Excluding Unusual Items
3,5723,1372,7523,317
Asset Writedown
---29-
Other Unusual Items
-66-255-27
Pretax Income
3,5723,2032,4683,290
Income Tax Expense
912802658816
Net Income
2,6602,4011,8102,474
Net Income to Common
2,6602,4011,8102,474
Net Income Growth
33.00%32.65%-26.82%-
Shares Outstanding (Basic)
23232323
Shares Outstanding (Diluted)
23232323
Shares Change
0.01%---
EPS (Basic)
115.49104.2578.59107.40
EPS (Diluted)
115.49104.2578.59107.40
EPS Growth
32.99%32.65%-26.82%-
Free Cash Flow
2,6501,6724,291-66
Free Cash Flow Per Share
115.0672.60186.32-2.87
Dividend Per Share
-75.00055.000-
Dividend Growth
-36.36%--
Gross Margin
74.14%73.46%74.09%72.51%
Operating Margin
35.77%33.85%36.73%39.07%
Profit Margin
28.01%27.33%24.98%29.69%
Free Cash Flow Margin
27.90%19.04%59.23%-0.79%
EBITDA
3,4643,0252,6833,282
EBITDA Margin
36.47%34.44%37.03%39.40%
D&A For EBITDA
67522227
EBIT
3,3972,9732,6613,255
EBIT Margin
35.77%33.85%36.73%39.07%
Effective Tax Rate
25.53%25.04%26.66%24.81%
Revenue as Reported
9,6938,9687,3758,393
Advertising Expenses
-359204-